Wahiduzzaman M, Yasmin A, Shahriar Hossain M, Dhar R, Haider MM. Efficacy and safety of empagliflozin (SGLT2 inhibitor) in Bangladeshi patients with type 2 diabetes mellitus. Int J Res Med Sci [Internet]. 2025 Nov. 28 [cited 2026 Feb. 2];13(12):5150-4. Available from: https://www.msjonline.org/index.php/ijrms/article/view/15838